PHILADELPHIA — Angiotensin receptor blockers were associated with worse outcomes in patients with celiac disease, including anemia, iron deficiency and “continued mucosal damage in the small intestine ...

(HealthDay News) — Angiotensin receptor blockers (ARBs) are just as effective and safe as angiotensin-converting enzyme inhibitors (ACEIs), according to research published in Mayo Clinic Proceedings.

Angiotensin receptor blockers (ARBs), particularly losartan, are associated with a lower risk for incident epilepsy in patients with hypertension and no preexisting stroke or cardiovascular disease ...

A class of drugs already on the market to lower blood pressure appears to reduce adults' risk of developing epilepsy, Stanford Medicine researchers and their colleagues have discovered. The finding ...

Researchers found that the incidence of epilepsy was reduced with use of ARBs vs ACEs, β-blockers, and a combination of other antihypertensive classes. HealthDay News — For patients with hypertension, ...

In a recent study published in the BMJ, researchers conducted a phase three, multicenter, randomized controlled trial to evaluate the effect of using angiotensin receptor blockers that disrupt the ...

Patients with albuminuric chronic kidney disease without diabetes can experience a significantly increased survival free of kidney failure if treated with the combination of angiotensin receptor ...